CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE
According to a story from BioPortfolio, the biopharmaceutical company GW Pharmaceuticals plc recently announced that its medicine Epidyolex has earned recommendation from the UK National Institute for Health and Care…